Patents

US 10017475 B2: Anti-vasculature and anti-tubulin combretastatin analogs for treatment of cancer

Granted
2018-07-10
Filed
2015-03-26 application 15129785
Type
Utility · 11 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Combretastatins analog compounds and their pharmaceutically acceptable salts are presented, as well as pharmaceutical compositions comprising the combretastatin analog compounds and uses of the combretastatin analog compounds, either alone or in combination with at least one additional therapeutic agent, in the treatment of cancer, and in particular cancer presenting as metastatic tumors.

Source: PVGPATDIS, file of 2026-04-10 (ipg180710.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Xavier University of Louisiana 14 patentsUS company or organizationNew Orleans, LAXavier University of Louisiana College or university EXACT high confidence: identical full name and state
XAVIER UNIVERSITY OF LOUISIANA Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Guangdi WangNew Orleans, LA11PVGPATDIS, file of 2026-04-10
Shilong ZhengNew Orleans, LA8PVGPATDIS, file of 2026-04-10
Qiu ZhongNew Orleans, LA22PVGPATDIS, file of 2026-04-10
Qiang ZhangMetairie, LA531PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D213/61PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/4418PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2016-11-12Assignment
Assignment of assignor's interest
WANG, GUANGDI signed 2016-09-28
ZHANG, QIANG signed 2016-09-28
ZHENG, SHILONG signed 2016-09-28
ZHONG, QIU signed 2016-09-28
XAVIER UNIVERSITY OF LOUISIANA NEW ORLEANS, LA40299/139ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.